EDITAS MEDICINE, INC. (EDIT)

Every figure this model derived for EDIT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 691,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 211,645,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 218,067,000 AssetsCurrent 2026-06-30
current liabilities 68,434,000 LiabilitiesCurrent 2026-06-30
equity 105,281,000 StockholdersEquity 2026-06-30
interest expense 6,171,000 InterestExpenseDebt 2025-12-31
ocf -119,859,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 47,005,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 8,652,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up EDIT on one particular measure came for.

RatioValue
cash operating margin-137.82
current ratio6.04
current ratio reported3.19
deferred revenue growth5071.09
dilution pct7.79
fcf margin-256.46
growth cv4.03
interest cover-12.29
operating margin-161.39
owner earnings margin-274.87
revenue growth20.83
revenue growth per share12.1
rule of 40-140.55
sbc pct revenue18.41

What to be careful about

What this model itself distrusts about EDIT's figures. Written by the derivation as it ran, not added afterwards.